Dong Emily, Lam Cynthia, Tang Danming, Louie Salina, Yim Mandy, Williams Ambrose J, Sawyer William, Yip Shirley, Carver Joseph, AlBarakat Ali, Tsukuda Joni, Snedecor Brad, Misaghi Shahram
Cell Culture and Bioprocess Operations Department, Genentech, Inc. 1 DNA Way, South San Francisco, California, USA.
Purification Development Department, Genentech, Inc. 1 DNA Way, South San Francisco, California, USA.
Biotechnol J. 2021 Apr;16(4):e2000230. doi: 10.1002/biot.202000230. Epub 2020 Dec 30.
Complex recombinant proteins are increasingly desired as potential therapeutic options for many disease indications and are commonly expressed in the mammalian Chinese hamster ovary (CHO) cells. Generally, stoichiometric expression and proper folding of all subunits of a complex recombinant protein are required to achieve the desired titers and product qualities for a complex molecule. Targeted integration (TI) cell line development (CLD), which entails the insertion of the desired transgene(s) into a predefined landing-pad in the CHO genome, enables the generation of a homogeneous pool of cells from which clonally stable and high titer clones can be isolated with minimal screening efforts. Despite these advantages, using a single transgene(s) configuration with predetermined gene dosage might not be adequate for the expression of complex molecules. The goal of this study is to develop a method for seamless screening of many vector configurations in a single TI CLD attempt. As testing vector configurations in transient expression systems is not predictive of protein expression in the stable cell lines and parallel TI CLDs with different transgene configurations is resource-intensive, we tested the concept of randomized configuration targeted integration (RCTI) CLD approach for expression of complex molecules. RCTI allows simultaneous transfection of multiple vector configurations, encoding a complex molecule, to generate diverse TI clones each with a single transgene configuration but clone specific productivity and product qualities. Our findings further revealed a direct correlation between transgenes' configuration/copy-number and titer/product quality of the expressed proteins. RCTI CLD enabled, with significantly fewer resources, seamless isolation of clones with comparable titers and product quality attributes to that of several parallel standard TI CLDs. Therefore, RCTI introduces randomness to the TI CLD platform while maintaining all the advantages, such as clone stability and reduced sequence variant levels, that the TI system has to offer.
复杂重组蛋白作为许多疾病适应症的潜在治疗选择越来越受到青睐,并且通常在中国仓鼠卵巢(CHO)细胞中表达。一般来说,复杂重组蛋白的所有亚基需要化学计量表达和正确折叠,以实现复杂分子所需的滴度和产品质量。靶向整合(TI)细胞系开发(CLD),即将所需转基因插入CHO基因组中的预定义着陆位点,能够产生同质细胞群,从中可以通过最少的筛选工作分离出克隆稳定且高滴度的克隆。尽管有这些优点,但使用具有预定基因剂量的单一转基因配置可能不足以表达复杂分子。本研究的目的是开发一种在单次TI CLD尝试中无缝筛选多种载体配置的方法。由于在瞬时表达系统中测试载体配置无法预测稳定细胞系中的蛋白质表达,并且使用不同转基因配置进行平行TI CLD资源密集,我们测试了随机配置靶向整合(RCTI)CLD方法用于表达复杂分子的概念。RCTI允许同时转染编码复杂分子的多种载体配置,以产生每个具有单一转基因配置但具有克隆特异性生产力和产品质量的不同TI克隆。我们的研究结果进一步揭示了转基因的配置/拷贝数与所表达蛋白质的滴度/产品质量之间的直接相关性。RCTI CLD能够以显著更少的资源无缝分离出滴度和产品质量属性与几个平行标准TI CLD相当的克隆。因此,RCTI在TI CLD平台中引入了随机性,同时保留了TI系统所具有的所有优点,如克隆稳定性和降低的序列变异水平。